Indivumed collects and processes solid tumor tissue across all cancer types using our ISO-certified standardized protocol. This innovative and market-leading approach enables research with comparably-processed tissues regardless of whether they are derived from different tumor entities, different patients, or different clinics on the globe.
Together with extremely short ischemia times and standardized sample preparation, we ensure the best quality and, subsequently, the best research data. Our customers benefit from outstanding expertise in tissue collection (together with clinical data procurement), tissue processing, and tissue qualification, performed by our dedicated in-house pathology and data management team. All actions follow the Indivumed Standard Operating Procedure, which adheres to stringent processes to collect and preserve biospecimen. This generates samples that retain patterns of biomolecules such as RNA, DNA, and protein as closely comparable to their state when in the human body as possible. All Indivumed biobanking procedures follow strict ethical standards.
The resulting biospecimen products and clinical data sets cover the complete range of client needs.
With clinical data’s potential to help detect trends and potential causes of cancer, we consider our extensive collection one of our greatest assets.
The clinical data sets that Indivumed provides stem from fully consenting and informed patients and their medical records, notes taken during surgical tumor resection, and comprehensive interviews with the patient and his or her physician. Following surgery, long-term and follow-up data are collected annually.
For every patient, we document approximately 320 data points. All available data is thoroughly cross-checked in regard to completeness, correctness, and plausibility before being stored in Indivumed’s Oracle-based database, IndivuNET.
Three different types of clinical data sets are available:
Information on the medical history of the patient and his or her family, lifestyle, quality of life, the pathology report, results of standardized routine lab tests, and pre-surgical diagnostic data.
Information on tissue ischemia times, sample storage, the accrual, sample location within the tumor, anesthesiological and surgical procedures which might affect molecular patterns, and histopathology of resected tissue.
Information on post-surgical complications, treatment after primary surgery, survival, and outcome.